Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Stroke. 2012 Jan 26;43(4):1101–1107. doi: 10.1161/STROKEAHA.111.620088

Figure 2. HIF-1α, EPO, pAkt/Akt, and pErk/Erk contents and EPOR mRNA expression in HT22 neuronal cells.

Figure 2

A) 10 mM pyruvate increased HIF-1α and EPO contents in parallel with Akt activation. B) Immunoblot band densities in pyruvate-treated cells were normalized to respective controls (*P<0.05 vs. Control). C) EPOR mRNA expression was evaluated with real time RT-PCR (*P<0.05 vs. Normoxic control; †P<0.05 vs. Hypoxic control).